GTHX - G1 Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue---522
Cost of Revenue70,68353,88125,16112,730
Gross Profit-70,683-53,881-25,161-12,208
Operating Expenses
Research Development----
Selling General and Administrative18,6037,0875,2303,216
Non Recurring----
Others----
Total Operating Expenses89,28660,96830,39115,946
Operating Income or Loss-89,286-60,968-30,391-15,424
Income from Continuing Operations
Total Other Income/Expenses Net7,996847100-4,839
Earnings Before Interest and Taxes-89,286-60,968-30,391-15,424
Interest Expense----
Income Before Tax-85,288-60,121-30,291-20,263
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-85,288-60,121-30,291-20,263
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-85,288-60,121-30,291-20,263
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-85,288-64,878-34,696-21,690